von Redaktion LCGC | Mai 15, 2011
Early Prediction of Nonprogression in Advanced Non-Small-Cell Lung Cancer Treated With Erlotinib By Using [18F]Fluorodeoxyglucose and [18F]Fluorothymidine Positron Emission Tomography Zander T, Scheffler M, Nogova L, Kobe C, Engel-Riedel W, Hellmich M, Papachristou I,...
von Redaktion LCGC | März 15, 2011
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial (ZEAL) De Boer RH, Arrieta O, Yang C-H, Gottfried M, Chan V, Raats J, De Marinis F, Abratt RP, Wolf J, Blackhall FH, Langmuir P,...
von Redaktion LCGC | Feb. 15, 2011
Molecular diagnostics of lung cancer for treatment stratification Heukamp LC, Wolf J, Buettner R Journal: Der Internist Vol 52, No 2, February 2012, doi: 10.1007/s00108-010-2698-yVeröffentlichung: Februar...
